The impact of the COVID-19 pandemic on respiratory syncytial virus infection: a narrative review
Respiratory syncytial virus (RSV) is one of the most common respiratory viruses. It not only
affects young children but also the elderly and immunocompromised patients. After the …
affects young children but also the elderly and immunocompromised patients. After the …
Viral bronchiolitis in children
HC Meissner - New England Journal of Medicine, 2016 - Mass Medical Soc
Viral Bronchiolitis in Children | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH The New England Journal …
England Journal of Medicine homepage Advanced Search SEARCH The New England Journal …
Respiratory syncytial virus seasonality: a global overview
P Obando-Pacheco, AJ Justicia-Grande… - The Journal of …, 2018 - academic.oup.com
Respiratory syncytial virus (RSV) is the leading cause of acute lower respiratory infections in
children. By the age of 1 year, 60%–70% of children have been infected by RSV. In addition …
children. By the age of 1 year, 60%–70% of children have been infected by RSV. In addition …
Impact of COVID‐19 social distancing on viral infection in France: A delayed outbreak of RSV
C Delestrain, K Danis, I Hau, S Behillil… - Pediatric …, 2021 - Wiley Online Library
Introduction COVID‐19 pandemic and associated lockdown measures have deeply modified
the natural course of seasonal viral infections, such as respiratory syncytial virus (RSV) …
the natural course of seasonal viral infections, such as respiratory syncytial virus (RSV) …
Defining the seasonality of respiratory syncytial virus around the world: national and subnational surveillance data from 12 countries
L Staadegaard, S Caini, S Wangchuk… - Influenza and other …, 2021 - Wiley Online Library
Background Respiratory syncytial virus (RSV) infections are one of the leading causes of
lower respiratory tract infections and have a major burden on society. For prevention and …
lower respiratory tract infections and have a major burden on society. For prevention and …
WHO consultation on respiratory syncytial virus vaccine development report from a World Health Organization meeting held on 23–24 March 2015
K Modjarrad, B Giersing, DC Kaslow, PG Smith… - Vaccine, 2016 - Elsevier
Respiratory syncytial virus (RSV) is a globally prevalent cause of lower respiratory infection
in neonates and infants. Despite its disease burden, a safe and effective RSV vaccine has …
in neonates and infants. Despite its disease burden, a safe and effective RSV vaccine has …
Human respiratory syncytial virus and influenza seasonality patterns—early findings from the WHO global respiratory syncytial virus surveillance
M Chadha, S Hirve, C Bancej, I Barr… - Influenza and other …, 2020 - Wiley Online Library
Background Human respiratory syncytial virus (RSV) causes illnesses among all age groups
and presents a burden to healthcare services. To better understand the epidemiology and …
and presents a burden to healthcare services. To better understand the epidemiology and …
[HTML][HTML] Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants
G Rainisch, B Adhikari, MI Meltzer, G Langley - Vaccine, 2020 - Elsevier
Background Palivizumab, a monoclonal antibody and the only licensed immunization
product for preventing respiratory syncytial virus (RSV) infection, is recommended for …
product for preventing respiratory syncytial virus (RSV) infection, is recommended for …
The burden of respiratory syncytial virus in adults: a systematic review and meta-analysis
MTT Htar, MS Yerramalla, JC Moïsi… - Epidemiology & …, 2020 - cambridge.org
Respiratory syncytial virus (RSV) is the most common pathogen associated with acute lower
respiratory tract infections in young children. RSV is also a major viral pathogen causing …
respiratory tract infections in young children. RSV is also a major viral pathogen causing …